Radotinib is a tyrosine kinase inhibitor.
The global Radotinib market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Radotinib is a selective BCR-ABL1-specific second-generation tyrosine kinase inhibitor.
In terms of production side, this report researches the Radotinib production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
In terms of consumption side, this report focuses on the sales of Radotinib by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2029.
Report Includes:
This report presents an overview of global market for Radotinib, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Radotinib, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Radotinib, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Radotinib sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Radotinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Radotinib sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including APExBIO Technology LLC, Biorbyt Ltd., BioVision,Inc., Cayman Chemical Company, Selleck Chemicals, Target Molecule Corp. and Absin, etc.
By Company
APExBIO Technology LLC
Biorbyt Ltd.
BioVision,Inc.
Cayman Chemical Company
Selleck Chemicals
Target Molecule Corp.
Absin
Segment by Type
Powder
Solution
Segment by Application
Research Laboratory
Hospital
Others
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Radotinib production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Radotinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Radotinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radotinib sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Radotinib Product Introduction
1.2 Market by Type
1.2.1 Global Radotinib Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Powder
1.2.3 Solution
1.3 Market by Application
1.3.1 Global Radotinib Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Research Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Radotinib Production
2.1 Global Radotinib Production Capacity (2018-2029)
2.2 Global Radotinib Production by Region: 2018 VS 2022 VS 2029
2.3 Global Radotinib Production by Region
2.3.1 Global Radotinib Historic Production by Region (2018-2023)
2.3.2 Global Radotinib Forecasted Production by Region (2024-2029)
2.3.3 Global Radotinib Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Radotinib Revenue Estimates and Forecasts 2018-2029
3.2 Global Radotinib Revenue by Region
3.2.1 Global Radotinib Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Radotinib Revenue by Region (2018-2023)
3.2.3 Global Radotinib Revenue by Region (2024-2029)
3.2.4 Global Radotinib Revenue Market Share by Region (2018-2029)
3.3 Global Radotinib Sales Estimates and Forecasts 2018-2029
3.4 Global Radotinib Sales by Region
3.4.1 Global Radotinib Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Radotinib Sales by Region (2018-2023)
3.4.3 Global Radotinib Sales by Region (2024-2029)
3.4.4 Global Radotinib Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Radotinib Sales by Manufacturers
4.1.1 Global Radotinib Sales by Manufacturers (2018-2023)
4.1.2 Global Radotinib Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Radotinib in 2022
4.2 Global Radotinib Revenue by Manufacturers
4.2.1 Global Radotinib Revenue by Manufacturers (2018-2023)
4.2.2 Global Radotinib Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Radotinib Revenue in 2022
4.3 Global Radotinib Sales Price by Manufacturers
4.4 Global Key Players of Radotinib, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Radotinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Radotinib, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Radotinib, Product Offered and Application
4.8 Global Key Manufacturers of Radotinib, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Radotinib Sales by Type
5.1.1 Global Radotinib Historical Sales by Type (2018-2023)
5.1.2 Global Radotinib Forecasted Sales by Type (2024-2029)
5.1.3 Global Radotinib Sales Market Share by Type (2018-2029)
5.2 Global Radotinib Revenue by Type
5.2.1 Global Radotinib Historical Revenue by Type (2018-2023)
5.2.2 Global Radotinib Forecasted Revenue by Type (2024-2029)
5.2.3 Global Radotinib Revenue Market Share by Type (2018-2029)
5.3 Global Radotinib Price by Type
5.3.1 Global Radotinib Price by Type (2018-2023)
5.3.2 Global Radotinib Price Forecast by Type (2024-2029)
6 Market Size by Application
6.1 Global Radotinib Sales by Application
6.1.1 Global Radotinib Historical Sales by Application (2018-2023)
6.1.2 Global Radotinib Forecasted Sales by Application (2024-2029)
6.1.3 Global Radotinib Sales Market Share by Application (2018-2029)
6.2 Global Radotinib Revenue by Application
6.2.1 Global Radotinib Historical Revenue by Application (2018-2023)
6.2.2 Global Radotinib Forecasted Revenue by Application (2024-2029)
6.2.3 Global Radotinib Revenue Market Share by Application (2018-2029)
6.3 Global Radotinib Price by Application
6.3.1 Global Radotinib Price by Application (2018-2023)
6.3.2 Global Radotinib Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Radotinib Market Size by Type
7.1.1 US & Canada Radotinib Sales by Type (2018-2029)
7.1.2 US & Canada Radotinib Revenue by Type (2018-2029)
7.2 US & Canada Radotinib Market Size by Application
7.2.1 US & Canada Radotinib Sales by Application (2018-2029)
7.2.2 US & Canada Radotinib Revenue by Application (2018-2029)
7.3 US & Canada Radotinib Sales by Country
7.3.1 US & Canada Radotinib Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Radotinib Sales by Country (2018-2029)
7.3.3 US & Canada Radotinib Revenue by Country (2018-2029)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Radotinib Market Size by Type
8.1.1 Europe Radotinib Sales by Type (2018-2029)
8.1.2 Europe Radotinib Revenue by Type (2018-2029)
8.2 Europe Radotinib Market Size by Application
8.2.1 Europe Radotinib Sales by Application (2018-2029)
8.2.2 Europe Radotinib Revenue by Application (2018-2029)
8.3 Europe Radotinib Sales by Country
8.3.1 Europe Radotinib Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Radotinib Sales by Country (2018-2029)
8.3.3 Europe Radotinib Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Radotinib Market Size by Type
9.1.1 China Radotinib Sales by Type (2018-2029)
9.1.2 China Radotinib Revenue by Type (2018-2029)
9.2 China Radotinib Market Size by Application
9.2.1 China Radotinib Sales by Application (2018-2029)
9.2.2 China Radotinib Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Radotinib Market Size by Type
10.1.1 Asia Radotinib Sales by Type (2018-2029)
10.1.2 Asia Radotinib Revenue by Type (2018-2029)
10.2 Asia Radotinib Market Size by Application
10.2.1 Asia Radotinib Sales by Application (2018-2029)
10.2.2 Asia Radotinib Revenue by Application (2018-2029)
10.3 Asia Radotinib Sales by Region
10.3.1 Asia Radotinib Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Radotinib Revenue by Region (2018-2029)
10.3.3 Asia Radotinib Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Radotinib Market Size by Type
11.1.1 Middle East, Africa and Latin America Radotinib Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Radotinib Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Radotinib Market Size by Application
11.2.1 Middle East, Africa and Latin America Radotinib Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Radotinib Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Radotinib Sales by Country
11.3.1 Middle East, Africa and Latin America Radotinib Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Radotinib Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Radotinib Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 APExBIO Technology LLC
12.1.1 APExBIO Technology LLC Company Information
12.1.2 APExBIO Technology LLC Overview
12.1.3 APExBIO Technology LLC Radotinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 APExBIO Technology LLC Radotinib Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 APExBIO Technology LLC Recent Developments
12.2 Biorbyt Ltd.
12.2.1 Biorbyt Ltd. Company Information
12.2.2 Biorbyt Ltd. Overview
12.2.3 Biorbyt Ltd. Radotinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Biorbyt Ltd. Radotinib Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Biorbyt Ltd. Recent Developments
12.3 BioVision,Inc.
12.3.1 BioVision,Inc. Company Information
12.3.2 BioVision,Inc. Overview
12.3.3 BioVision,Inc. Radotinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 BioVision,Inc. Radotinib Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 BioVision,Inc. Recent Developments
12.4 Cayman Chemical Company
12.4.1 Cayman Chemical Company Company Information
12.4.2 Cayman Chemical Company Overview
12.4.3 Cayman Chemical Company Radotinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Cayman Chemical Company Radotinib Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Cayman Chemical Company Recent Developments
12.5 Selleck Chemicals
12.5.1 Selleck Chemicals Company Information
12.5.2 Selleck Chemicals Overview
12.5.3 Selleck Chemicals Radotinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Selleck Chemicals Radotinib Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Selleck Chemicals Recent Developments
12.6 Target Molecule Corp.
12.6.1 Target Molecule Corp. Company Information
12.6.2 Target Molecule Corp. Overview
12.6.3 Target Molecule Corp. Radotinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Target Molecule Corp. Radotinib Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Target Molecule Corp. Recent Developments
12.7 Absin
12.7.1 Absin Company Information
12.7.2 Absin Overview
12.7.3 Absin Radotinib Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Absin Radotinib Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Absin Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Radotinib Industry Chain Analysis
13.2 Radotinib Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Radotinib Production Mode & Process
13.4 Radotinib Sales and Marketing
13.4.1 Radotinib Sales Channels
13.4.2 Radotinib Distributors
13.5 Radotinib Customers
14 Radotinib Market Dynamics
14.1 Radotinib Industry Trends
14.2 Radotinib Market Drivers
14.3 Radotinib Market Challenges
14.4 Radotinib Market Restraints
15 Key Finding in The Global Radotinib Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
APExBIO Technology LLC
Biorbyt Ltd.
BioVision,Inc.
Cayman Chemical Company
Selleck Chemicals
Target Molecule Corp.
Absin
*If Applicable.